Crinetics Pharmaceuticals (CRNX) EBITDA Margin (QoQ) (2017 - 2026)
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78,044.00 |
| Mar 31, 2026 | 86,176.00 |
| Dec 31, 2025 | 9.75 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Jun 30, 2024 | -925,871.00 |
| Sep 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -357,297.00 |
| Mar 31, 2023 | 491,658.00 |
| Dec 31, 2022 | 278,030.00 |
| Sep 30, 2022 | 31,747.00 |
| Jun 30, 2022 | -872,485.00 |
| Mar 31, 2022 | 178,492.00 |
| Mar 31, 2020 | -2.03 Mn |
| Dec 31, 2019 | -172,392.00 |
| Mar 31, 2019 | -152,923.00 |
| Dec 31, 2018 | 26,507.00 |
| Sep 30, 2018 | -60,764.00 |
| Jun 30, 2018 | 38,523.00 |
| Mar 31, 2018 | -77,655.00 |